- Home
- MBOT vs GOSS Comparison
MBOT vs GOSS Comparison
Compare MBOT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBOT | GOSS |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 70.8M |
| IPO Year | 2000 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MBOT | GOSS |
|---|---|---|
| Price | $1.08 | $10.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $5.38 | ★ $95.40 |
| AVG Volume (30 Days) | ★ 765.1K | 221.8K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.27 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $116,887.00 | ★ $48,471,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $377.83 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $0.11 |
| 52 Week High | $2.86 | $12.52 |
Technical Indicators
Market Signals| Indicator | MBOT | GOSS |
|---|---|---|
| Relative Strength Index (RSI) | 46.86 | 58.71 |
| Support Level | N/A | $0.18 |
| Resistance Level | $2.69 | $12.49 |
| Average True Range (ATR) | 0.06 | 0.79 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 65.91 | 71.68 |
Price Performance
Historical ComparisonAbout MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).